Related Experiment Videos
[Study of flow cytometric BrdU/DNA assay].
Nihon Gan Chiryo Gakkai Shi
|June 20, 1989
Summary
This study shows flow cytometry can rapidly assess cancer drug effectiveness and detect resistant cells early. This method aids in selecting optimal cancer chemotherapy by identifying drug resistance.
Area of Science:
- Cell Biology
- Pharmacology
- Oncology
Context:
- Developing rapid chemosensitivity assays is crucial for effective cancer chemotherapy.
- Mouse leukemic L1210 cell lines, both CDDP-sensitive and CDDP-resistant, were used for preliminary studies.
Purpose:
- To evaluate the flow cytometric Bromodeoxyuridine (BrdU)/DNA assay as a rapid chemosensitivity test.
- To determine if this method can accurately assess the effects of cisplatin (CDDP) on cancer cells.
Summary:
- The flow cytometric BrdU/DNA assay effectively determined the anticancer effects of CDDP on L1210 cells by analyzing cell kinetics and BrdU uptake.
- This method demonstrated high sensitivity, detecting CDDP-resistant cells at proportions as low as 0.1% in a sensitive population.
Impact:
- This flow cytometry technique offers a rapid screening tool for anticancer drugs in initial cancer chemotherapy.
- It can serve as a monitoring test to quickly identify drug-resistant cells, guiding more effective anticancer therapy selection.